We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR, GALEN MARKETING SWAP PROMPTS FTC INQUIRY
BARR, GALEN MARKETING SWAP PROMPTS FTC INQUIRY
January 13, 2004
Antitrust regulators are examining a proposed deal between Barr Laboratories and Galen Holdings that would settle patent litigation and swap marketing rights on several oral contraceptive and hormone-replacement drugs.